51 related articles for article (PubMed ID: 10659047)
1. Stabilization and formulation of a recombinant Human Cytomegalovirus vector for use as a candidate HIV-1 vaccine.
Kumru OS; Saleh-Birdjandi S; Antunez LR; Sayeed E; Robinson D; van den Worm S; Diemer GS; Perez W; Caposio P; Früh K; Joshi SB; Volkin DB
Vaccine; 2019 Oct; 37(44):6696-6706. PubMed ID: 31548012
[TBL] [Abstract][Full Text] [Related]
2. Trial Launches of New HIV Vaccine Candidate With CMV Vector.
Harris E
JAMA; 2023 Oct; 330(16):1515. PubMed ID: 37792382
[No Abstract] [Full Text] [Related]
3. HIV: the pursuit of an elusive vaccine.
Coulson A
Biotechniques; 2023 Aug; 75(2):39-41. PubMed ID: 37539869
[TBL] [Abstract][Full Text] [Related]
4. Vaccine strategies for the
Sharan R; Kaushal D
NPJ Vaccines; 2020; 5():95. PubMed ID: 33083030
[TBL] [Abstract][Full Text] [Related]
5. Chronic Immune Activation in TB/HIV Co-infection.
Sharan R; Bucşan AN; Ganatra S; Paiardini M; Mohan M; Mehra S; Khader SA; Kaushal D
Trends Microbiol; 2020 Aug; 28(8):619-632. PubMed ID: 32417227
[TBL] [Abstract][Full Text] [Related]
6. HIV vaccines: progress to date.
Munier CM; Andersen CR; Kelleher AD
Drugs; 2011 Mar; 71(4):387-414. PubMed ID: 21395355
[TBL] [Abstract][Full Text] [Related]
7. Efficiency of recombinant bacille Calmette-Guérin in inducing humoral and cell mediated immunities against human immunodeficiency virus type 1 third variable domain in immunized mice.
Kim YJ
Yonsei Med J; 2011 Jan; 52(1):173-80. PubMed ID: 21155051
[TBL] [Abstract][Full Text] [Related]
8. Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.
Someya K; Cecilia D; Ami Y; Nakasone T; Matsuo K; Burda S; Yamamoto H; Yoshino N; Kaizu M; Ando S; Okuda K; Zolla-Pazner S; Yamazaki S; Yamamoto N; Honda M
J Virol; 2005 Feb; 79(3):1452-62. PubMed ID: 15650171
[TBL] [Abstract][Full Text] [Related]
9. The ability of heat-killed Mycobacterium vaccae to stimulate a cytotoxic T-cell response to an unrelated protein is associated with a 65 kilodalton heat-shock protein.
Skinner MA; Prestidge R; Yuan S; Strabala TJ; Tan PL
Immunology; 2001 Feb; 102(2):225-33. PubMed ID: 11260328
[TBL] [Abstract][Full Text] [Related]
10. Recombinant Mycobacterium bovis bacillus Calmette-Guerin elicits human immunodeficiency virus type 1 envelope-specific T lymphocytes at mucosal sites.
Yu JS; Peacock JW; Jacobs WR; Frothingham R; Letvin NL; Liao HX; Haynes BF
Clin Vaccine Immunol; 2007 Jul; 14(7):886-93. PubMed ID: 17507541
[TBL] [Abstract][Full Text] [Related]
11. AIDS vaccine research in Asia: needs and opportunities. Report from a UNAIDS/WHO/NIID meeting Tokyo, 28-30 October 1998.
AIDS; 1999 Jul; 13(11):UNAIDS 1-UNAIDS 13. PubMed ID: 10449273
[TBL] [Abstract][Full Text] [Related]
12. Recombinant bacillus Calmette-Guérin as a potential vector for preventive HIV type 1 vaccines.
Falk LA; Goldenthal KL; Esparza J; Aguado MT; Osmanov S; Ballou WR; Beddows S; Bhamarapravati N; Biberfeld G; Ferrari G; Hoft D; Honda M; Jackson A; Lu Y; Marchal G; McKinney J; Yamazaki S
AIDS Res Hum Retroviruses; 2000 Jan; 16(2):91-8. PubMed ID: 10659047
[TBL] [Abstract][Full Text] [Related]
13. [The application of recombinant Bacillus Calmette-Guérin vaccine and its vector in infectious disease].
Zulpiya T; Ding J
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2013 Oct; 30(5):1136-40. PubMed ID: 24459985
[TBL] [Abstract][Full Text] [Related]
14. Optimizing HIV-1-specific CD8+ T-cell induction by recombinant BCG in prime-boost regimens with heterologous viral vectors.
Hopkins R; Bridgeman A; Bourne C; Mbewe-Mvula A; Sadoff JC; Both GW; Joseph J; Fulkerson J; Hanke T
Eur J Immunol; 2011 Dec; 41(12):3542-52. PubMed ID: 21932450
[TBL] [Abstract][Full Text] [Related]
15. Advances and challenges in recombinant Mycobacterium bovis BCG-based HIV vaccine development: lessons learned.
Kilpeläinen A; Maya-Hoyos M; Saubí N; Soto CY; Joseph Munne J
Expert Rev Vaccines; 2018 Nov; 17(11):1005-1020. PubMed ID: 30300040
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
